secwatch.observer — SEC 8-K summary
======================================

Issuer:     PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)
CIK:        0001299130
Form:       8-K/A
Filed at:   2024-12-13T23:59:59+00:00
Accession:  0001299130-24-000198
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Pacific Biosciences discloses CCO Jeff Eidel's separation terms: $485K severance, 12-month COBRA
--------------------------------------------------------------------------------

- Jeff Eidel's employment as CCO ended Nov 15, 2024; separation agreement signed Dec 6, effective Dec 13.
- Eidel receives lump sum of $485,000 (12 months base salary) and up to 12 months COBRA premium payments.
- Vested stock options must be exercised within 3 months of separation or forfeited; unvested RSUs/PSUs cancelled.
- Eidel agrees to release all claims, maintain confidentiality, and refrain from disparagement.
- Company will instruct executive officers and board to refrain from disparaging Eidel.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1299130/000129913024000198/0001299130-24-000198-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1299130/000129913024000198/pacb-20241111.htm
  HTML page:      https://secwatch.observer/filing/0001299130-24-000198

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer